Skip to Main Content

Paper Details

Inhibition of Granulocytic Myeloid-Derived Suppressor Cells Overcomes Resistance to Immune Checkpoint Inhibition in LKB1-Deficient Non-Small Cell Lung Cancer.
Cancer Res
51
2021
ATRA, ELR, G-, G-MDSCs, GEMM, Glu-Leu-Arg, Granulocytic Myeloid-Derived Suppressor Cells, ICI, KRAS, LKB1, LKB1-Deficient Non-Small Cell Lung Cancer, LKB1-deficent, LKB1-deficent murine tumors, LKB1-deficient NSCLC, LKB1-deficient non-small cell lung cancer, LKB1-mutant NSCLC, MDSC, NH2, NSCLC, PD-1, T-cell, all-trans-retinoic acid, anti-PD-1, granulocytic myeloid-derived suppressor cells, murine, myeloid, myeloid-derived suppressor cells, non-small cell lung cancer, patients, premalignant and cancerous cells, tumor, tumors
Author NameAffiliation
Kostyantyn KrysanDavid Geffen School of Medicine at university of california los angeles
Steven M DubinettDavid Geffen School of Medicine at university of california los angeles
Steven M DubinettVA Greater Los Angeles Healthcare System
Steven M DubinettDavid Geffen School of Medicine at university of california los angeles
Steven M DubinettDavid Geffen School of Medicine at university of california los angeles
Steven M DubinettJonsson Comprehensive Cancer Center, university of california los angeles
Steven M DubinettDavid Geffen School of Medicine at university of california los angeles
Steven M DubinettVA Greater Los Angeles Healthcare System
Steven M DubinettDavid Geffen School of Medicine at university of california los angeles
Steven M DubinettDavid Geffen School of Medicine at university of california los angeles
Steven M DubinettJonsson Comprehensive Cancer Center, university of california los angeles
  • 1 - 11

Datasets

Release 1.2